Pulse Biosciences (PLSE) Research & Development (2015 - 2026)
Pulse Biosciences (PLSE) posted quarterly Research & Development of $11.4 million for Q3 2025, up 47.9% year-over-year from $7.7 million in Q3 2024, and down 5.75% quarter-over-quarter from $12.1 million in Q2 2025.
Pulse Biosciences (PLSE) Research & Development (2015 - 2026) Analysis & Trends
Pulse Biosciences' Research & Development history runs 11 years deep, the most recent figure standing at $11.4 million for Q3 2025.
- In Q3 2025, Research & Development rose 47.9% year-over-year to $11.4 million; the TTM figure through Sep 2025 stood at $44.5 million (up 50.84% YoY), while the FY2024 annual figure was $32.3 million, up 16.33% from the prior year.
- Research & Development for Q3 2025 stood at $11.4 million, down from $12.1 million in the prior quarter.
- The five-year high for Research & Development was $12.1 million in Q2 2025, with the low at $4.1 million in Q4 2022.
- The 5-year median for Research & Development is $7.2 million (2024), against an average of $7.5 million.
- The sharpest annual moves came in 2022 and 2023: Research & Development tumbled 30.08% in 2022, then jumped 90.45% in 2023.
- Pulse Biosciences' Research & Development stood at $5.7 million in 2021, then slipped by 27.62% to $4.1 million in 2022, then jumped by 90.45% to $7.8 million in 2023, then jumped by 36.71% to $10.7 million in 2024, then advanced by 6.86% to $11.4 million in 2025.
- Business Quant data shows PLSE's Research & Development at $11.4 million in Q3 2025, $12.1 million in Q2 2025, and $10.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Pulse Biosciences | 3.33 Bn | 3.33 Bn | 161,000.00 | 16.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.98 Mn |
| Sep 30, 2025 | 11.39 Mn |
| Jun 30, 2025 | 12.09 Mn |
| Mar 31, 2025 | 10.31 Mn |
| Dec 31, 2024 | 10.66 Mn |
| Sep 30, 2024 | 7.70 Mn |
| Jun 30, 2024 | 7.23 Mn |
| Mar 31, 2024 | 6.74 Mn |
| Dec 31, 2023 | 7.80 Mn |
| Sep 30, 2023 | 7.47 Mn |
| Jun 30, 2023 | 6.70 Mn |
| Mar 31, 2023 | 5.83 Mn |
| Dec 31, 2022 | 4.10 Mn |
| Sep 30, 2022 | 4.52 Mn |
| Jun 30, 2022 | 5.46 Mn |
| Mar 31, 2022 | 6.77 Mn |
| Dec 31, 2021 | 5.66 Mn |
| Sep 30, 2021 | 6.46 Mn |
| Jun 30, 2021 | 7.46 Mn |
| Mar 31, 2021 | 9.06 Mn |